Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2023 Mar 21;14:1183107. doi: 10.3389/fimmu.2023.1183107

Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection

Frontiers Production Office1,*
PMCID: PMC10072902  PMID: 37026018

An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding provided by University of Lausanne”.

The original version of this article has been updated.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES